50847-09-1N#Cc1nc(Br)[nH]c1C#NWMPWSWMSTJAAPF-UHFFFAOYSA-N50847-09-1DTXSID70381292Danger
H301 (50%): Toxic if swallowed [Danger Acute toxicity, oral]
P261, P262, P264, P264+P265, P270, P271, P280, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P316, P317, P319, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Uses2-Bromo-1H-imidazole-4,5-dicarbonitrile is used as an intermediate in organic synthesis or in the pharmaceutical industry. This compound can be utilised in the preparation of imidazodazine-type hepatitis C virus polymerase inhibitors and candidate drugs for the treatment of kidney disease.
Loading…